Searching for a cure, Improving lives

Join our team! Genetics DMD Registry Officer role

Posted on: November 29th, 2017 | 0 comments

  • Competitive salary dependent on qualifications and experience
  • Permanent role
  • Full time (37.5 hours per week)
  • Location: Flexible (office is based in E11, London)
  • 25 days holiday plus bank holidays

The Genetics DMD Registry Officer role – in detail

Lead the development of dynamic Charity Action Duchenne’s patient registry to ensure optimised scope of data, efficient data collection, data analysis and wide data utility and compatibility with co-registries in the UK. Plan for the foreseeable future needs of translational research in Duchenne Muscular Dystrophy.

Summary of key tasks

  • Strategically plan and lead the development of The Registry with the guidance and support of the DMD Registry Curator
  • As relevant strategically investigating the UK database landscape and strategically develop the database itself in the context of clinical trial recruitment in the UK. Making suggestions to improve current Registry system with new initiatives and proposals
  • Gain an understanding The Registry process, then explore and investigate future needs with a view to keeping ahead of research advancements to meet the needs of future researchers
  • Provide an overview of all UK databases to address any gaps and bottlenecks in the field of information selected and collected that would enhance data generation by all future translational research and clinical trials in the UK
  • Ensure all information for the Registry can be collected efficiently and accuractely, and put processes in place to maintain data (up to date and correct)
  • Identify and implement improvements in data collection, analysis and reporting
  • Maintain the registry IT-system and liaise with web designer for the purpose of functionality
  • Liaise with Curator to produce reports for the Trustees, CEO and Steering Committee
  • Liaise with Chair of Steering Committee and committee members
  • Attend meetings regarding usage and advancement of The Registry with health professionals
  • Support Action Duchenne conferences, workshops, seminars and attend staff training as required
  • Maintain high productivity and work quality standards
  • Maintain confidentiality at all times

Overview of the Charity

Founded in 2001, Action Duchenne was the first UK charity dedicated to improving the lives of those living with Duchenne Muscular Dystrophy. Our vision is that people living with Duchenne live the longer, fuller lives they deserve.

The UK DMD Registry was developed by Action Duchenne in 2007 and acts as a database for all those living with Duchenne or Becker Muscular Dystrophy. Patient registration is an online process that is voluntary and confidential. The Registry collects information including genetic diagnosis, some clinical function information and interventions.

Genetics DMD Registry Officer person specification

We are looking for an analytical individual with a sound knowledge of genetics to support the DMD Registry Curator and to lead on the Registry’s future development and planning. To ensure the collection and analysis of data is accurate, efficient and to implement improvements to future-proof the Registry. It is an exciting time for Duchenne translational research as there are around 40 clinical trials taking place now with new trials planned across the UK. It is a great opportunity for the successful candidate to be at the centre and forefront of these developments and to ensure the DMD Registry continues to be a bespoke database used by patients, clinicians, geneticists and researchers alike.

Click for detailed person spec

How to apply

  • To apply, please send your CV with a brief covering letter or email.
  • Closing date is Friday 5 January 2018 5.00pm.
  • Please send written applications to Angela Stringer, Action Duchenne, Epicentre, 41 West Street, London E11 4LJ or apply below.

Interview process

  • Only suitable candidates will be contacted for a brief, informal telephone interview.
  • Final interviews will take place on Monday 22 January.

About the DMD Registry

The DMD Registry acts as a database for all patients who have been diagnosed with Duchenne or Becker Muscular Dystrophy and female carriers. Participants are required to give consent before registering and also to complete a Medical Release Form (consent form) to enable Action Duchenne to contact clinicians and geneticists for medical and genetic information. Participants are also required to read the Terms and Conditions carefully when registering and to ask any questions before making a decision whether or not to participate.

Registration and access is only authorised to people who are registered with a clinician in their country of residence because they have been diagnosed as having either Duchenne or Becker Muscular Dystrophy, are a carrier of a variant in the Dystrophin gene or are the parent or guardian of a child with a variant in the Dystrophin gene.

Purpose of the Registry

  • To develop and encourage the development of more research into Duchenne and Becker Muscular Dystrophy
  • Facilitate research by collecting relevant data and making it available for specified research projects
  • Use the information provided to understand the disease better
  • Establish contact between clinicians, other health professionals, researchers and Registry participants
  • Enhance clinicians’ and other health professionals’ ability to deliver treatments for this disease

Importance of the DMD Registry

Patient registries are a very important tool in translational research. When planning a clinical trial, it is important that eligible patients can be found and contacted quickly – particularly in DMD, where many therapies and trials are targeted at specific mutations. With relatively few patients both eligible and willing to participate in any given trial, international cooperation is critically important.

The UK DMD Registry is part of the TREAT-NMD Global DMD Registry. National DMD registries from 34 countries contribute a subset of their data into a single international registry. This holds a standardised set of core clinical information, including full genetic diagnosis, for over 7,000 individuals. This data is anonymous: personally identifiable information, such as names and addresses, are never uploaded to the Global Registry.

By collecting information, including genetic diagnosis, about more patients than any one national registry could on its own, the Global DMD registry helps researchers plan effective clinical trials and other studies. The UK DMD Registry is an important part of this effort. The role of Genetics DMD Registry Officer is key to curating the current Registry and implementing future data strategies to sustain the utility of the Registry as a translational tool to enable clinical developments in Duchenne.

How to apply

  • To apply, please send your CV with a brief covering letter or email.
  • Closing date is Friday 5 January 2018 5.00pm.
  • Please send written applications to Angela Stringer, Action Duchenne, Epicentre, 41 West Street, London E11 4LJ or apply below.

Interview process

  • Only suitable candidates will be contacted for a brief, informal telephone interview.
  • Final interviews will take place on Monday 22 January.

Leave a Reply

Your email address will not be published. Required fields are marked *


Support Action Duchenne with a monthly or one off donation



View our events

View All Events


Join the DMD registry for access to clinical trials


Action Duchenne launches new Research Strategy for Duchenne muscular dystrophy

November 17th, 2017

  Action Duchenne, a leading UK-wide patient and parent-led organisation for Duchenne Muscular Dystrophy, is

Tell me more

Long-term microdystrophin pre-clinical work, moving towards a potential therapy restores muscle function in canines

July 26th, 2017

Promising microdystrophin pre-clinical work, moving towards a potential therapy has shown to restore muscle function

Tell me more

FDA new approach would reduce number of patients treated with placebo

December 11th, 2017

The U.S. Food and Drug Administration (FDA) has published its recommendation for a new approach

Tell me more

Results announced from survey ‘Juggling care and daily life’

December 11th, 2017

The 17th October 2017 was an important date for the rare disease community.  The highlights of the

Tell me more

Duchenne – How do you measure a life?

Living with Duchenne – an animation

Taking charge of Duchenne

wordpress counter

Stay informed with regular updates from Action Duchenne